(Q33793810)

29 July 2017

1 reference

title

Succinylcholine: adverse effects and alternatives in emergency medicine (English)

1 reference

29 July 2017

1 reference

Orebaugh SL

1

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 November 1999

1 reference

American Journal of Emergency Medicine

29 July 2017

published in

1 reference

29 July 2017

volume

17

1 reference

29 July 2017

issue

7

1 reference

29 July 2017

page(s)

715-721

1 reference

Adverse effects of depolarising neuromuscular blocking agents. Incidence, prevention and management

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Pharmacology and clinical use of neuromuscular blocking agents

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Pharmacokinetics of succinylcholine in infants, children, and adults

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Effect of d-tubocurarine pretreatment on succinylcholine twitch augmentation and neuromuscular blockade.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Temporal correlation of succinylcholine-induced fasciculations to loss of twitch response at different stimulating frequencies.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Comparison of intubating conditions after administration of Org 9246 (rocuronium) and suxamethonium

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Critical hemoglobin desaturation will occur before return to an unparalyzed state following 1 mg/kg intravenous succinylcholine

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Suxamethonium and hyperkalaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Mode of action of neuromuscular blocking agents

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Plasma potassium after halothane--suxamethonium induction in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Serum potassium changes during induction of anaesthesia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Changes in plasma potassium and calcium levels and in the electrocardiogram after a single dose of succinylcholine preceded by d-tubocurarine

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Synergistic Effect of Acidosis and Succinylcholine-Induced Hyperkalemia in Spinal Cord Transected Rats

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

The use of succinylcholine in open eye surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

The open globe: is an alternative to succinylcholine necessary?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Inhibition of succinylcholine-induced increased intragastric pressure by nondepolarizing muscle relaxants and lidocaine.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

The effect of thiopentone and suxamethonium on gastrooesophageal pressure gradients [proceedings]

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Muscle relaxation with succinylcholine or vecuronium does not alter the rate of CSF production or resistance to reabsorption of CSF in dogs.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Succinylcholine and intracranial pressure--a cause for "pause"

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Succinylcholine and cardiac excitability

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Adverse effects of neuromuscular blocking drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Succinylcholine, cholinoceptors and catecholamines: proposed mechanism of early adverse haemodynamic reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Bradycardia following sufentanil-succinylcholine

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

The Advantages of Giving d-Tubocurarine before Succinylcholine

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Pancuronium Pretreatment and Post-succinylcholine Myalgias

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Objective Measurement of Succinylcholine-induced Fasciculations and the Effect of Pretreatment with Pancuronium or Gallamine

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Prevention of succinylcholine myalgias: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Cardiac arrest after succinylcholine administration in a pregnant patient recovered from Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Hyperkalemia after succinylcholine administration in a patient with closed head injury without paresis.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Succinylcholine-Induced Ventricular Fibrillation in the Paralyzed Urology Patient

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Succinylcholine-induced hyperkalemia in patients with ruptured cerebral aneurysms

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Changes in serum potassium response to succinylcholine following trauma

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

The serum potassium response to muscle relaxants in neural injury

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Succinylcholine—Danger in the Spinal-cord-injured Patient

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Paraplegia, Succinylcholine and Cardiac Arrest

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Cardiac Arrest Following Succinylcholine in Patients with Central Nervous System Injuries

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Suxamethonium is dangerous in polyneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Hyperkalemia and Cardiovascular Collapse Following Administration of Succinylcholine to the Traumatized Patient

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Intractable cardiac arrest in children given succinylcholine

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Pretreatment with non-depolarizing neuromuscular blocking agents and suxamethonium-induced increases in resting jaw tension in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Masseter muscle spasm in children: implications of continuing the triggering anesthetic

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Masseter spasm with anesthesia: incidence and implications

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Is there a relationship between masseteric muscle spasm and malignant hyperpyrexia?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Management of patients in whom trismus occurs following succinylcholine

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Malignant hyperthermia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Halothane-caffeine contracture testing in neuromuscular diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

The inhibitory effect of d-tubocurarine on the increase of serum-creatine-kinase activity produced by intermittent suxamethonium administration during halothane anaesthesia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Myoglobinemia after a Single Dose of Succinylcholine

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Non-relaxant properties of neuromuscular blocking drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Anesthetics responsible for anaphylactic shock. A French multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Muscle relaxants and histamine release.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Adverse reactions to suxamethonium and other muscle relaxants under general anestesia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Fatal reaction to suxamethonium: case for screening by radioallergosorbent test?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Resistance to succinylcholine in myasthenia gravis: a dose-response study.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Succinylcholine Neuromuscular Blockade in Subjects Heterozygous for Abnormal Plasma Cholinesterase

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

The effect of a series of anti-cancer drugs on plasma cholinesterase activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Ecothiopate iodide eye drops and prolonged response to suxamethonium

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

New neuromuscular blocking drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Pharmacokinetics of mivacurium in normal patients and in those with hepatic or renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Time course of action and intubating conditions following vecuronium, rocuronium and mivacurium.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Anesthesiology. First of two parts

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Comparison of the neuromuscular block induced by mivacurium, suxamethonium or atracurium during nitrous oxide-fentanyl anaesthesia.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Intubating conditions and neuromuscular block after divided dose mivacurium or single dose rocuronium.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Histamine-release haemodynamic changes produced by rocuronium, vecuronium, mivacurium, atracurium and tubocurarine

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

A comparison of the intubation conditions between mivacurium and rocuronium during balanced anesthesia.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

A comparison between mivacurium and suxamethonium in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Clinical responses to ORG 9426 during isoflurane anesthesia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Rocuronium onset of action: a comparison with atracurium and vecuronium

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Comparison of rocuronium, succinylcholine, and vecuronium for rapid-sequence induction of anesthesia in adult patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Onset and duration of rocuronium and succinylcholine at the adductor pollicis and laryngeal adductor muscles in anesthetized humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Intubating conditions and onset of neuromuscular block of rocuronium (Org 9426); a comparison with suxamethonium

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Influence of induction technique on intubating conditions after rocuronium in adults: comparison with rapid-sequence induction using thiopentone and suxamethonium.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Different priming techniques, including mivacurium, accelerate the onset of rocuronium.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

A mixture of mivacurium and rocuronium is comparable in clinical onset to succinylcholine.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

Neuromuscular effects of rocuronium bromide (Org 9426) during fentanyl and halothane anaesthesia.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2899%2990168-7

7 January 2021

10.1016/S0735-6757(99)90168-7

Identifiers

DOI

1 reference

release_3iwy2x2kizawflzxxrzobihj4e

29 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3iwy2x2kizawflzxxrzobihj4e

24 November 2022

mapped directly with Wikidata item

1 reference